GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Immune Pharmaceuticals Inc. (IMNP) [hlAlert]

Rating:
Buy EPCT
up 93.03 %

Epicept Corporation (EPCT) rated Buy with price target $1.50 by Dawson James

Posted on: Thursday,  Mar 31, 2011  9:25 AM ET by Dawson James

Dawson James rated Buy Immune Pharmaceuticals Inc. (NASDAQ: IMNP) on 03/31/2011, when the stock price was $0.69. Since
then, Immune Pharmaceuticals Inc. has gained 93.03% as of 01/13/2016's recent price of $1.33.
If you would have followed this Dawson James's recommendation on IMNP, you would have gained 93.03% of your investment in 1749 days.

EpiCept Corporation (EpiCept) is a specialty pharmaceutical company focused on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. It focuses its clinical development efforts on cancer therapies and topically delivered analgesics targeting peripheral nerve receptors. Its lead product is Ceplene, which when used concomitantly with low-dose interleukin-2 (IL-2) is intended as remission maintenance therapy in the treatment of acute myeloid leukemia (AML) for adult patients who are in their first complete remission. In addition to Ceplene, EpiCept has two other oncology compounds, including crolibulin, a small molecule vascular disruption agent (VDA), and apoptosis inducer for the treatment of patients with solid tumors and Azixa, an apoptosis inducer with VDA activity, which is in Phase II clinical trials in patients with primary glioblastoma and cancer that has metastasized to the brain.

Dawson James Securities is a full service investment firm with deep expertise in healthcare, biotechnology and technology with a staff of over 50 investment professionals ensures our clients stay ahead of the constant changes in the healthcare capital markets. From our widely-respected institutional research, investment banking and high net worth services to our personalized attention for individual accounts, we provide quality service for our clients. We take pride in the quality and depth of our professionals and encourage you to contact us so we can begin serving your financial needs today.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/31/2011 9:25 AM Buy
None
0.69 1.50
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy